Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Infra Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | KUMAR AND BROTHERSLikely | RA Ended | 1 | ₹1,860 |
| 2 | Schedule 2 | KUMAR AND BROTHERSLikely | RA Ended | 1 | ₹4,026 |
| 3 | Schedule 3 | AMAR MEDICOLikely | RA Ended | 1 | ₹1,680 |
| 4 | Schedule 4 | KUMAR AND BROTHERSLikely | RA Ended | 1 | ₹1,312.50 |
| 5 | Schedule 5 | KUMAR AND BROTHERSLikely | RA Ended | 1 | ₹14,334 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
16 May 2024, 8:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
ETHAMBUTOL 800 MG TAB (Q3)
ETHINYL ESTRADIOL 0.1 MG+ DESOGESTREL 0.2 MG Tab (Q3)
ETIZOLAM 0.25 Mg Tab (Q3)
Eye Drop Tobramycin0.3% 5 ml (Q3)
EYE OINT HYPROMELLOSE 2% (HYDROXYPROPYL METHYLCELLULOSE 2% OCULAR LUBE) (Q3)
EZETIMIBE 10 MG TAB (Q3)
FLUOCINOLONE 0.1% W/V SHAMPOO (Q3)
FOOT DROP SPLINT (Q3)
Hydroquinone 2% Ointment (Q3)
Hydroxychloroquine 300 Mg Tab (Q3)
INJ DEXTROSE 25% (Q3)
INJ DEXTROSE 50% (Q3)
LACOSAMIDE 100MG TAB (Q3)
Lactobaciilus (Sporolac) Tab (Q3)
Lamotrigine 25mg Tab (Q3)
Lamotrigine 50mg Tab (Q3)
Mesalamine sachet (Q3)
Mesalamine Suppository (Q3)
NEBIVOLOL 2.5 MG TAB (Q3)
Nebivolol 5 mg Tab (Q3)
6305811
GEM/2024/B/4855539
Two Packet Bid
ETHAMBUTOL 800 MG TAB,ETHINYL ESTRADIOL 0.1 MG+ DESOGESTREL 0.2 MG Tab,ETIZOLAM 0.25 Mg Tab,Eye Dro
30 days
Punjab; Amritsar
Item wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
3 yrs
₹3
80%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| ETHAMBUTOL 800 MG TAB (Q3) | AMRITSAR | 300 | 30 days | |
| ETHINYL ESTRADIOL 0.1 MG+ DESOGESTREL 0.2 MG Tab (Q3) | AMRITSAR | 600 | 30 days | |
| ETIZOLAM 0.25 Mg Tab (Q3) | AMRITSAR | 1,500 | 30 days | |
| Eye Drop Tobramycin0.3% 5 ml (Q3) | AMRITSAR | 150 | 30 days | |
| EYE OINT HYPROMELLOSE 2% (HYDROXYPROPYL METHYLCELLULOSE 2% OCULAR LUBE) (Q3) | AMRITSAR | 150 | 30 days | |
| EZETIMIBE 10 MG TAB (Q3) | AMRITSAR | 1,170 | 30 days | - |
| FLUOCINOLONE 0.1% W/V SHAMPOO (Q3) | AMRITSAR | 912 | 30 days | |
| FOOT DROP SPLINT (Q3) | AMRITSAR | 15 | 30 days | |
| Hydroquinone 2% Ointment (Q3) | AMRITSAR | 45 | 30 days | |
| Hydroxychloroquine 300 Mg Tab (Q3) | AMRITSAR | 2,400 | 30 days | |
| INJ DEXTROSE 25% (Q3) | AMRITSAR | 60 | 30 days | |
| INJ DEXTROSE 50% (Q3) | AMRITSAR | 30 | 30 days | |
| LACOSAMIDE 100MG TAB (Q3) | AMRITSAR | 6,030 | 30 days | - |
| Lactobaciilus (Sporolac) Tab (Q3) | AMRITSAR | 4,500 | 30 days | |
| Lamotrigine 25mg Tab (Q3) | AMRITSAR | 600 | 30 days | |
| Lamotrigine 50mg Tab (Q3) | AMRITSAR | 1,800 | 30 days | |
| Mesalamine sachet (Q3) | AMRITSAR | 300 | 30 days | |
| Mesalamine Suppository (Q3) | AMRITSAR | 195 | 30 days | |
| NEBIVOLOL 2.5 MG TAB (Q3) | AMRITSAR | 900 | 30 days | |
| Nebivolol 5 mg Tab (Q3) | AMRITSAR | 6,300 | 30 days | - |
Exempted
16 May 2024
25 Apr 2024
16 May 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6305811.pdf
GEM_BID
re-33_2024-04-11-10-18-39_367956c2b45544c6706a442600603f07.pdf
SPECIFICATION
re-33_2024-04-11-10-19-03_ff77319d0ec4a97da009e04275fc27f8.pdf
SPECIFICATION
re-33_2024-04-11-10-19-24_0b62ec9a944a0d5ab32cadb4fdb4662f.pdf
SPECIFICATION
re-33_2024-04-11-10-19-48_9f8420c4417a461d444fe44dde01b182.pdf
SPECIFICATION
re-33_2024-04-11-10-20-11_32a1f03b5d774f3cafc7186f1af3b7de.pdf
SPECIFICATION
re-33_2024-04-11-10-20-33_a15bd075cf9b4399809bed72e9874901.pdf
SPECIFICATION
re-33_2024-04-11-10-20-59_40aad05828826c96af9dd746364d3a5f.pdf
SPECIFICATION
re-33_2024-04-11-10-21-19_1fcea3110633a5234e11b56aafc4b749.pdf
SPECIFICATION
re-33_2024-04-11-10-21-40_56fdeabc7ee0b062376ed2c0960ae6c1.pdf
SPECIFICATION
re-33_2024-04-11-10-22-08_efe55f4823245717bea4c6b33f6950bc.pdf
SPECIFICATION
re-33_2024-04-11-10-22-31_51fc2544a7eaffae58254b0a3d91e022.pdf
SPECIFICATION
re-33_2024-04-11-10-23-04_9c0ef7a7a222695fc304c61fa6e765ea.pdf
SPECIFICATION
re-33_2024-04-11-10-23-25_28abb0bf92ab0d4e3bd3d13711249dbc.pdf
SPECIFICATION
re-33_2024-04-11-10-23-46_9e0c4cea6b267f91b3886000b2e41410.pdf
SPECIFICATION
re-33_2024-04-11-10-24-08_c8375f78d0104bdf41c4fec30a99ec04.pdf
SPECIFICATION
re-33_2024-04-11-10-24-41_e6a88edac1e1836001ef5dd6fd2eaa53.pdf
SPECIFICATION
re-33_2024-04-11-10-25-02_9dfffdc2d9e8eede65528e0ec93b39b1.pdf
SPECIFICATION
re-33_2024-04-11-10-25-23_f155276973c6e7e7d0c2b9ba639398e5.pdf
SPECIFICATION
re-33_2024-04-11-10-25-46_2f94b822eadcbdd6b7fb339235ad67b2.pdf
SPECIFICATION
re-33_2024-04-11-10-26-07_9305ae5eee6c35377684e57e5cdd120f.pdf
SPECIFICATION
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .